Ear zaps may steady heart and BP in Parkinson's

NCT ID NCT07557706

Recruiting now Symptom relief Sponsor: University of Alabama at Birmingham Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This early study tests whether a gentle, non-invasive nerve stimulation device placed in the ear (taVNS) can improve how the body regulates heart rate and blood pressure in people with Parkinson's disease. Researchers will measure changes during simple physical tasks like deep breathing and standing up. The goal is to see if taVNS could one day support physical therapy and daily function.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: transcutaneous auricular vagus nerve stimulation (taVNS) device
What this could lead to: If it works, this could point toward a non-drug way to help people with Parkinson's manage blood pressure and heart rate issues, making daily activities and exercise easier.
What could go wrong: This is a very early Phase 1 study with only 24 people. It is designed to test basic body responses, not to prove a treatment works. The effects may be small or not helpful in real life.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PARKINSON DISEASE (DISORDER) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Parkinson disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PARKINSON DISEASE (DISORDER)

Contacts and locations

Locations

Wellness, Health and Research Facility at UAB
RECRUITING

Birmingham, Alabama, 35209, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.